Exchange: NASDAQ·Updated 12:00 AM EST

RPTX Repare Therapeutics Inc

$2.64
$0.00
(0.00%)
Pre-Market
Prev Close $2.64
Reported EarningsNov 14
Mkt Cap$114.24M

About RPTX

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
43

Bearish Sentiment

How do you feel about RPTX?

Advertisement|Remove ads.